Giovanna Fattovich

Summary

Affiliation: University of Verona
Country: Italy

Publications

  1. ncbi Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years
    G Fattovich
    Department of Gastroenterology, University of Verona, Verona, Italy
    Gut 57:84-90. 2008
  2. ncbi Post-load insulin resistance does not predict virological response to treatment of chronic hepatitis C patients without the metabolic syndrome
    Giovanna Fattovich
    Department of Medicine, University of Verona, Verona, Italy
    Dig Liver Dis 44:419-25. 2012
  3. ncbi IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C
    G Fattovich
    Clinic of Gastroenterology, Department of Medicine, University of Verona, Piazzale L A Scuro 10, Verona, Italy
    Aliment Pharmacol Ther 33:1162-72. 2011
  4. ncbi The homeostasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients
    Giovanna Fattovich
    Department of Medicine, University of Verona, Verona, Italy
    Liver Int 31:66-74. 2011
  5. ncbi Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors
    Giovanna Fattovich
    Department of Surgical and Gastroenterological Sciences, University of Verona, Piazzale L A Scuro, 10, Verona 37134, Italy
    J Hepatol 48:335-52. 2008
  6. ncbi Natural history and prognosis of hepatitis B
    Giovanna Fattovich
    Servizio Autonomo Clinicizzato di Gastroenterologia, University of Verona, Italy
    Semin Liver Dis 23:47-58. 2003
  7. ncbi Hepatocellular carcinoma in cirrhosis: incidence and risk factors
    Giovanna Fattovich
    Department of Gastroenterology, University of Verona, Verona, Italy
    Gastroenterology 127:S35-50. 2004
  8. ncbi Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients
    Giovanna Fattovich
    Servizio Autonomo Clinicizzato di Gastroenterologia, University of Verona, Italy
    Am J Gastroenterol 97:2886-95. 2002
  9. ncbi Focal liver lesions in cirrhosis: value of contrast-enhanced ultrasonography compared with Doppler ultrasound and alpha-fetoprotein levels
    M D'Onofrio
    Department of Radiology, B Rossi University Hospital, University of Verona, Policlinico G B Rossi, Piazzale L A Scuro 10, 37134 Verona, Italy
    Radiol Med 113:978-91. 2008
  10. ncbi Accuracy of ultrasound in the detection of liver fibrosis in chronic viral hepatitis
    Mirko D'Onofrio
    Istituto di Radiologia, Policlinico Universitario G B Rossi, Verona, Italy
    Radiol Med 110:341-8. 2005

Detail Information

Publications19

  1. ncbi Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years
    G Fattovich
    Department of Gastroenterology, University of Verona, Verona, Italy
    Gut 57:84-90. 2008
    ..To assess risk factors for liver-related death, we re-evaluated, after a median follow-up of 25 years, a cohort of 70 Caucasian patients with hepatitis B e antigen (HBeAg) positive chronic hepatitis (CH) at presentation...
  2. ncbi Post-load insulin resistance does not predict virological response to treatment of chronic hepatitis C patients without the metabolic syndrome
    Giovanna Fattovich
    Department of Medicine, University of Verona, Verona, Italy
    Dig Liver Dis 44:419-25. 2012
    ..8 mg/kg/min) with the rapid and sustained virological responses in chronic hepatitis C...
  3. ncbi IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C
    G Fattovich
    Clinic of Gastroenterology, Department of Medicine, University of Verona, Piazzale L A Scuro 10, Verona, Italy
    Aliment Pharmacol Ther 33:1162-72. 2011
    ..Hepatitis C virus (HCV) is a major cause of chronic liver disease, cirrhosis and hepatocellular carcinoma and the identification of the predictors of response to antiviral therapy is an important clinical issue...
  4. ncbi The homeostasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients
    Giovanna Fattovich
    Department of Medicine, University of Verona, Verona, Italy
    Liver Int 31:66-74. 2011
    ..To investigate the independent association between the homeostasis model assessment of the insulin resistance (HOMA-IR) score and rapid virological response (RVR) and sustained virological response (SVR) in chronic hepatitis C (CHC)...
  5. ncbi Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors
    Giovanna Fattovich
    Department of Surgical and Gastroenterological Sciences, University of Verona, Piazzale L A Scuro, 10, Verona 37134, Italy
    J Hepatol 48:335-52. 2008
    ..There is a growing understanding of viral, host and environmental factors influencing disease progression, which ultimately could improve the management of chronic hepatitis B...
  6. ncbi Natural history and prognosis of hepatitis B
    Giovanna Fattovich
    Servizio Autonomo Clinicizzato di Gastroenterologia, University of Verona, Italy
    Semin Liver Dis 23:47-58. 2003
    ..Both cirrhotic and noncirrhotic patients with sustained reduction of HBV replication and normalization of aminotransferase after interferon alfa therapy have a reduced risk for liver-related complications...
  7. ncbi Hepatocellular carcinoma in cirrhosis: incidence and risk factors
    Giovanna Fattovich
    Department of Gastroenterology, University of Verona, Verona, Italy
    Gastroenterology 127:S35-50. 2004
    ..Further studies are needed to investigate other viral factors (eg, HBV genotype/mutant, occult HBV, HIV coinfection) and preventable or treatable comorbidities (eg, obesity, diabetes) in the HCC risk in cirrhosis...
  8. ncbi Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients
    Giovanna Fattovich
    Servizio Autonomo Clinicizzato di Gastroenterologia, University of Verona, Italy
    Am J Gastroenterol 97:2886-95. 2002
    ..Survival shows no significant differences according to HBV or HCV etiology in Western European cirrhotic patients...
  9. ncbi Focal liver lesions in cirrhosis: value of contrast-enhanced ultrasonography compared with Doppler ultrasound and alpha-fetoprotein levels
    M D'Onofrio
    Department of Radiology, B Rossi University Hospital, University of Verona, Policlinico G B Rossi, Piazzale L A Scuro 10, 37134 Verona, Italy
    Radiol Med 113:978-91. 2008
    ....
  10. ncbi Accuracy of ultrasound in the detection of liver fibrosis in chronic viral hepatitis
    Mirko D'Onofrio
    Istituto di Radiologia, Policlinico Universitario G B Rossi, Verona, Italy
    Radiol Med 110:341-8. 2005
    ..To assess the accuracy of ultrasonography (US) in the identification and grading of hepatic fibrosis in patients afflicted with chronic viral liver disease, compared to histological examination as a gold standard...
  11. ncbi Natural history of hepatitis B
    Giovanna Fattovich
    Servizio Autonomo Clinicizzato di Gastroenterologia, Dipartimento di Scienze Chirurgiche e Gastroenterologiche, University of Verona, Piazzale L.A. Scuro n. 10, 37134 Verona, Italy
    J Hepatol 39:S50-8. 2003
  12. ncbi Reduced serum hepcidin levels in patients with chronic hepatitis C
    Domenico Girelli
    Department of Clinical and Experimental Medicine, University of Verona, Policlinico G B Rossi, Verona, Italy
    J Hepatol 51:845-52. 2009
    ....
  13. ncbi Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe
    G Fattovich
    Servizio Autonomo Clinicizzato di Gastroenterologia, University of Verona, Policlinoco G.B. Rossi, Piazzale L. Scuro 10, 37134 Verona, Italy
    J Viral Hepat 8:206-16. 2001
    ..HCV type 1b is not associated with a greater risk for HCC, but increases the risk for decompensation by threefold in patients with cirrhosis...
  14. ncbi A randomized trial of prolonged high dose of interferon plus ribavirin for hepatitis C patients nonresponders to interferon alone
    G Fattovich
    Servizio Autonomo Clinicizzato di Gastroenterologia, Universita di Verona, Verona, Italy
    J Viral Hepat 11:543-51. 2004
    ..Induction therapy does not improve SVR...
  15. ncbi Efficacy of prolonged 5 million units of interferon in combination with ribavirin for relapser patients with chronic hepatitis C
    G Fattovich
    Servizio Autonomo Clinicizzato di Gastroenterologia, Universita di Verona, Verona, Italy
    J Viral Hepat 10:111-7. 2003
    ..Our study suggests that relapsed patients with genotype 1 or 4 may achieve significant response rates of approximately 50%, if retreated with 5 MU tiw IFN plus ribavirin for 48 weeks...
  16. ncbi Risk factors for hepatocellular carcinoma in HCV-cirrhosis: what we know and what is missing
    Giovanna Fattovich
    J Hepatol 44:1013-6. 2006
  17. ncbi Effects of interferon plus ribavirin treatment on NF-kappaB, TGF-beta1, and metalloproteinase activity in chronic hepatitis C
    Maria Guido
    Section of Anatomic Pathology, Department of Oncological and Surgical Science, University of Padova, Italy
    Mod Pathol 19:1047-54. 2006
    ..Combination therapy with interferon and ribavirin affects the tissue expression of TGF-beta-1 and NF-kappaB and favors metalloproteinase activity, and may thereby modulate hepatic fibrogenetic events...
  18. ncbi Intracellular distribution of hepatitis B virus core protein expressed in vitro depends on the sequence of the isolate and the serologic pattern
    Mohammed S Jazayeri
    Division of Virology, Institute of Biomedical and Life Science, University of Glasgow, Glasgow, Scotland
    J Infect Dis 189:1634-45. 2004
    ..Thus, the pattern of HBcAg localization in vitro depends on sequence and the serologic pattern of chronic infection, paralleling the situation in vivo...
  19. ncbi A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis C
    Giovanna Fattovich
    Servizio Autonomo Clinicizzato di Gastroenterologia, Universita di Verona, Piazzale LA Scuro 10, 37134 Verona, Italy
    J Hepatol 39:843-9. 2003
    ..The aim of the present, open-labeled, randomized study was to determine the efficacy and safety of different doses of consensus interferon plus ribavirin in the initial treatment of chronic hepatitis C...